Detalhe da pesquisa
1.
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells.
Cell
; 187(5): 1278-1295.e20, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387457